Connect with us

Business

AstraZeneca pauses £200m Cambridge investment

Published

on

AstraZeneca pauses £200m Cambridge investment


Mitchell LabiakBusiness reporter and

Simon JackBusiness editor

Getty Images Pharmaceutical company Astrazeneca's logo on the side of an office building with dark opaque windows. There is a grey sky behind the building.Getty Images

AstraZeneca has paused plans to invest £200m at a Cambridge research site in a fresh blow to the UK pharmaceutical industry.

The project, which was set to create 1,000 jobs, was announced in March 2024 by the previous government alongside another project in Liverpool, which was shelved in January.

Friday’s announcement comes after US pharmaceutical giant Merck scrapped a £1bn UK expansion, blaming a lack of government investment, and as President Donald Trump pressures pharmaceutical firms to invest more in the US.

An AstraZeneca spokesperson said: “We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused.”

Over the last 10 years, UK spending on medicines has fallen from 15% of the NHS budget to 9%, while the rest of the developed world spends between 14% and 20%.

Meanwhile, pharmaceutical companies have been looking to invest in the US following Trump’s threats of sky-high tariffs on drug imports.

In July, AstraZeneca said it would invest $50bn (£36.9bn) in the US on “medicines manufacturing and R&D [research and development]”.

Earlier this week Merck, which had already begun construction on a site in London’s King’s Cross which was due to be completed by 2027, said it no longer planned to occupy it.

The multi-national business, known as MSD in Europe, said it would move its life sciences research to the US and cut UK jobs, blaming successive governments for undervaluing innovative medicines.

Getty Images A close up of Pascal Soriot, chief executive officer of AstraZeneca Plc, speaking into a microphone during a signing ceremony event in Washington, DC in July where he was announcing the firm's $50bn investment in the US. He is wearing a dark suit and a white shirt and a US flag is in soft focus behind him.Getty Images

AstraZeneca boss Pascal Soriot announced the firm’s $50bn investment in the US in July

AstraZeneca’s announcement on Friday means none of the £650m UK investment trumpeted by the last government will currently happen.

The paused Cambridge project would have been an expansion of its existing Discovery Centre, which already hosts 2,300 researchers and scientists.

The stoppage comes after it scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside in January, blaming a reduction in government support.

It said at the time that after “protracted” talks, a number of factors influenced the move, including “the timing and reduction of the final offer compared to the previous government’s proposal”.

Successive UK governments have pointed to life sciences as one of its most successful industries.

Former chancellor Jeremy Hunt said the sector was “crucial for the country’s health, wealth and resilience” while Chancellor Rachel Reeves said AstraZeneca was one of the UK’s “great companies” days before it scrapped its Liverpool expansion.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Compensation scheme opens for victims of Post Office Capture IT scandal

Published

on

Compensation scheme opens for victims of Post Office Capture IT scandal



A scheme has been launched to compensate victims of the Post Office Capture IT scandal that saw former subpostmasters forced to repay shortfalls.

The Government said those affected can now apply for redress, with those found to be eligible set to receive £10,000 immediately and final awards potentially reaching up to £300,000 after full assessment by an independent panel, or more in certain cases.

The Capture system pre-dated the now infamous Horizon software, which has been responsible for around 1,000 wrongful convictions.

An independent report into faulty accounting system Capture was commissioned last year after subpostmasters said they had suffered similar problems to those faced by the Horizon victims.

The report by forensic accountants Kroll Associates, which concluded there was a reasonable likelihood that Capture – in use at Post Office branches between 1992 and 2000 – created financial shortfalls for postmasters.

In some cases, postmasters resorted to using their own savings to make up the difference.

The scheme will be not be open to postmasters who have criminal convictions related to Capture.

Those who were given criminal convictions must instead go through the Criminal Cases Review Commission, or its Scottish equivalent.

The Government has said it will “ensure that appropriate redress is given” to those where convictions are overturned by the courts.

The compensation scheme will be tested for the first 150 claimants before being rolled out more widely.

Post Office minister Blair McDougall said: “After over two decades of fighting for justice, postmasters and their families will finally receive recognition and recompense for the lives and livelihoods that Capture destroyed.

“I’d like to thank all of those victims who have helped us to design this scheme, allowing us to deliver on our promise of providing redress today.

“We can’t make up for everything they have lost, but today we begin restoring some of the dignity so cruelly taken away by this scandal.”

The Government said the scheme has been designed “hand in hand” with victims, while also taking lessons into account from redress schemes for the Horizon IT Scandal.

So far, more than £1.2 billion has been paid out in compensation to more than 9,000 victims of the Horizon scandal, it added.



Source link

Continue Reading

Business

ITR Due Date Extended: Businesses Get Time Till December 10, 2025 To File Returns

Published

on

ITR Due Date Extended: Businesses Get Time Till December 10, 2025 To File Returns



New Delhi: The Central Board of Direct Taxes (CBDT) has extended the due dates for filing audit reports and Income Tax Returns (ITR) for the Assessment Year 2025–26, giving major relief to businesses, professionals, and firms whose accounts require auditing.

Earlier, the deadline to submit tax audit reports was October 31, 2025, and the corresponding ITR filing deadline was also October 31, 2025. However, considering technical delays and representations from taxpayers and professionals, the CBDT has now extended both these dates.

As per the latest circular, taxpayers who are required to get their accounts audited under the Income Tax Act, 1961 can now file their audit reports by November 10, 2025, instead of October 31. Consequently, the due date for filing the ITR for such taxpayers has also been pushed to December 10, 2025.

Add Zee News as a Preferred Source


This extension applies to companies, Limited Liability Partnerships (LLPs), and other entities whose books of accounts need to be audited. It also benefits professionals and small businesses who were facing difficulties due to late availability of ITR forms and software utilities.

The government’s decision aims to provide adequate time for taxpayers and auditors to ensure accuracy and compliance while reducing last-minute rush and filing errors. The extension also reflects the government’s understanding of the challenges faced by the accounting community, especially with overlapping deadlines for GST audits and other financial filings.

Tax experts advise taxpayers to make the most of this extension by completing audits early and verifying data consistency between GST, TDS, and income tax returns to avoid discrepancies during assessment.

In summary, the new deadlines are:

Audit Report Filing: November 10, 2025

ITR Filing for Audited Taxpayers: December 10, 2025

Missing these dates could still attract penalties and interest, so taxpayers are urged to file well before the final deadline.

 

 



Source link

Continue Reading

Business

Gold Rates Tumble: Investors Shocked, But Jewellery Buyers Have A Reason To Smile

Published

on

Gold Rates Tumble: Investors Shocked, But Jewellery Buyers Have A Reason To Smile


Follow News18 on Google. Join the fun, play QIK games on News18. Stay updated with all the latest business news, including market trendsstock updatestax, IPO, banking finance, real estate, savings and investments. To Get in-depth analysis, expert opinions, and real-time updates. Also Download the News18 App to stay updated.



Source link

Continue Reading

Trending